Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.

European review for medical and pharmacological sciences - 1 Sept 2021

Spagnuolo R, Abenavoli L, Corea A, Larussa T, Mancina R M, Cosco C, Luzza F, Doldo P

Abstract excerpt

OBJECTIVE: Non-Alcoholic Fatty Liver Disease (NAFLD), as a hepatic manifestation of metabolic syndrome (MET)-related obesity, insulin resistance, dyslipidemia, and hypertension, is the main cause of chronic liver disease. Inflammatory Bowel Diseases (IBD), (Crohn's Disease (CD) and Ulcerative Colitis (UC)), are often associated with extraintestinal manifestations. Of these, NAFLD is one of the most frequently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acyltransferases
Share to Autophagy-Related Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyslipidemias

Share to GTP-Binding Proteins

Share to Inflammatory Bowel Diseases

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Share to Phospholipases A2, Calcium-Independent

Source

Identifiers

PMID: 34604973
DOI: 10.26355/eurrev_202109_26800

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review.PMID 34604973Read ↗

Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.Semantic proximity Read ↗

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.Semantic proximity Read ↗

The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Exploration of the core pathway of inflammatory bowel disease complicated with metabolic fatty liver and two-sample Mendelian randomization study of the causal relationships behind the disease.Semantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical ImplicationsSemantic proximity Read ↗

The gut microbiome and gut-liver axis in NAFLDSemantic proximity Read ↗

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).Semantic proximity Read ↗

Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches.Semantic proximity Read ↗

Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Integrated Bioinformatics Analysis Reveals Potential Mechanisms Associated with Intestinal Flora Intervention in Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with InflammationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.